Selank and Semax are two peptides originally developed in Russia that have become foundational subjects in nootropic and neurological research, both derived from naturally occurring immune and hormone-related peptide sequences.
Selank is a synthetic analog of tuftsin, an immunomodulatory peptide. Research has examined its effects on GABA and serotonin pathway activity, with studies focusing on anxiolytic, stress-response, and cognitive function models. Its stability in aqueous solution has made it a common subject of nasal-delivery research protocols.
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). Research on Semax has centered on its interaction with brain-derived neurotrophic factor (BDNF) expression and its potential relevance to memory, focus, and neuroprotection studies in laboratory models.
Why Researchers Study Them Together
Selank and Semax are frequently studied side by side because both act on overlapping neurological pathways while producing distinct research profiles: Selank research skews toward anxiolytic and stress modeling, while Semax research skews toward cognitive and neurotrophic modeling. Comparing the two allows researchers to map a broader picture of nootropic peptide activity.
Key Research Specifications
Purity: Research-grade Selank and Semax are typically supplied at greater than 98% purity, verified through HPLC testing.
Form: Both are commonly distributed as lyophilized powder, with some research formats available as pre-mixed nasal spray kits.
Storage: Unreconstituted vials should be kept frozen or refrigerated; once mixed, refrigerate and use within the recommended window.
Reconstitution: Bacteriostatic water is the standard diluent used in research protocols for both peptides.